Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen

Antiviral Therapy - United Kingdom
doi 10.3851/imp2182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press


Related search